RE: Reminder re FDA25 Feb 2021 10:22
"Awaiting EUA and full approval, FDA have no objection to the distribution of our test, I believe that was the precise wording"
Erm, you kind of missed out on a few key details
the FDA has stated that it does not object to a commercial manufacturer's development and distribution of SARS-CoV-2 test kits for specimen testing for a reasonable period of time, where the test has been validated and while the manufacturer has made an Emergency Use Authorization request, where the manufacturer gives appropriate notification of validation to FDA, and where the manufacturer provides instructions for use of the test and posts data about the test's performance characteristics on the manufacturer's website.